Vasodilator-stimulated phosphoprotein regulates arterial smooth muscle cell migration
Holt, Andrew W
This item will be available on: 2019-01-11
Cardiovascular disease (CVD) is a multi-faceted pathology that remains the number one killer of all Americans and people worldwide. Vascular inflammation, endothelial dysfunction, extracellular matrix imbalance, and arterial smooth muscle (ASM) cell proliferation and migration all contribute to the pathogenesis of occlusive CVD. Important roles for protein kinase signals in controlling aspects of ASM cell migration in the context of CVD are well documented in the scientific literature, and recent findings from our lab and others suggest post-translational modification (PTM) of downstream kinase targets could highlight unique mechanisms and thereby elucidate more precise pharmacotherapeutic targets to combat CVD. In this light, actin-binding vasodilator-stimulated phosphoprotein (VASP) is a critical regulator of adherent cell migration, a readout of protein kinase G (PKG) activity, and a potential attractive candidate for therapeutic intervention. We hypothesized that phosphorylation of VASP on Serine 239 (pVASP.S239) confers the anti-migratory effects of PKG in ASMs. Using in vivo and in vitro models with endogenous and exogenous stimulation of canonical PKG/VASP, we demonstrate the functional ability of this system to attenuate ASM cell migration in the context of CVD. Using site-directed mutagenesis (SDM) and rat cells expressing wild-type VASP, data suggest that pVASP.S239 negates the inhibitory effects of full-length VASP overexpression on cell migration and that this is reversed with a phosphorylation-resistant VASP mutant. Alternate to our hypothesis, these results suggest that pVASP.S239 is not effective in preventing or controlling pathologic ASM cell migration. Importantly however, using SDM along with pharmacologic kinase blockade, data reveal a novel negative feedback loop whereby pVASP.S239 suppresses PKG activity which can be rescued with PKG stimulation. Collectively, using newly developed and advanced techniques for studying cell migration in situ, these findings highlight the importance of VASP and establish the efficacy of PKG in attenuating uncontrolled ASM cell migration independent of pVASP.S239. Clinically, our data demonstrate a potential regulatory element that, with future examination, could lead to potential adjunctive therapies for occlusive vascular diseases involving ASM.
Holt, Andrew W. (September 2016). Vasodilator-stimulated phosphoprotein regulates arterial smooth muscle cell migration (Doctoral Dissertation, East Carolina University). Retrieved from the Scholarship. (http://hdl.handle.net/10342/5999.)
Holt, Andrew W. Vasodilator-stimulated phosphoprotein regulates arterial smooth muscle cell migration. Doctoral Dissertation. East Carolina University, September 2016. The Scholarship. http://hdl.handle.net/10342/5999. June 19, 2018.
Holt, Andrew W, “Vasodilator-stimulated phosphoprotein regulates arterial smooth muscle cell migration” (Doctoral Dissertation., East Carolina University, September 2016).
Holt, Andrew W. Vasodilator-stimulated phosphoprotein regulates arterial smooth muscle cell migration [Doctoral Dissertation]. Greenville, NC: East Carolina University; September 2016.
East Carolina University